相关实验视频
Updated: Jun 30, 2025

10:23
Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
3.2K
一种细菌毒素选择caspase-3来禁用活性气体皮质D,并限制巨细胞的热灭菌
Skylar S Wright1, Chengliang Wang1, Atri Ta2
1Department of Immunology, UConn Health School of Medicine, 263 Farmington Avenue, Farmington, CT 06030, USA.
Cell reports
|March 24, 2024
概括
肠出血性大肠杆菌 (EHEC) 使用Shiga毒素激活caspase-3,该毒素使气体皮质素D (GSDMD) 失活,并抑制热. 这揭示了一个新的细菌免疫逃避策略,针对活跃的GSDMD碎片.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 细胞生物学 细胞生物学
背景情况:
- 宿主细胞在感染期间遇到病原体相关的分子模式 (PAMPs) 和毒性因素,触发复杂的信号通路.
- 这些途径之间的相互作用决定了宿主-病原体相互作用的结果.
- 肠出血性大肠杆菌 (EHEC) 感染涉及脂多糖化物 (LPS) 和石加毒素 (Stx),激活不同的先天免疫反应.
研究的目的:
- 在EHEC感染期间阐明细菌外毒素和PAMP诱导的先天免疫路径之间的复杂相互作用.
- 为了研究 caspase-11 和 caspase-3 之间的功能相互作用,以应对 LPS 和 Stx.
- 发现新的细菌免疫逃避机制.
主要方法:
- 在EHEC感染期间调查酶激活和功能.
- 通过激活的caspases分析气皮素D (GSDMD) 的裂变.
- 评估这些相互作用对热致死和中白素-1β成熟的影响.
主要成果:
- 脂聚糖 (LPS) 激活的卡斯巴酶-11将全长的气体皮质D (GSDMD) 切割成一个活跃的N端片段 (NT-GSDMD).
- 由石毒素 (Stx) 激活的酶-3随后分裂NT-GSDMD,使其变得不起作用.
- 这种NT-GSDMD的失活抑制了热和白蛋白-1β的成熟,代表了一种独特的免疫逃避策略.
结论:
- 细菌毒素可以通过复杂的机制破坏宿主天生的免疫力.
- EHEC使用Shiga毒素来激活caspase-3,该毒素通过降解活性NT-GSDMD来对抗caspase-11的活性.
- 这一途径突出了一个新的细菌策略,通过向活跃的GSDMD来抑制热和IL-1β成熟.
相关概念视频
Caspases
12.5K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.5K
The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Phagocytosis of Apoptotic Cells
3.8K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.8K
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Overview of Cell Death
7.3K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.3K

